BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RM-718 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RM-718\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06239116-255@assetmemo.bio
DTSTAMP:20261121T004525Z
DTSTART;VALUE=DATE:20270507
DTEND;VALUE=DATE:20270508
SUMMARY:RM-718: Phase 1/2 readout est. (NCT06239116)
DESCRIPTION:RM-718\, phase 1/2\, Obesity.\nStudy: A Study of RM-718 in Heal
 thy Subjects and Patients With MC4R Pathway Impairment\nEstimated primary 
 completion: 7 May 2027. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/rm-718#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT06239116
URL:https://assetmemo.bio/drug/rm-718#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
